Subscribe To
Pbyi vs. amgn: which stock is the better value option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma ...
October 17, 2023, 12:46 pm
Evelo biosciences shares tank 46% after trial failure
Evelo Biosciences' shares have tumbled 46% in premarket trading after the biotech firm revealed disappo...
October 17, 2023, 9:00 am
Zymeworks to host third quarter 2023 results conference call
VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...
October 17, 2023, 8:30 am
Maravai lifesciences to host earnings conference call on tuesday, november 7, 2023
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and servi...
October 17, 2023, 8:15 am
The secrets behind a 4000% biotech stock surge
Remarkably, the stock did not have fundamentally changing news. It did not rocket higher on breaking news that would typically be associated with the ...
October 17, 2023, 8:06 am
Neurobo to present at the h.c. wainwright 7th annual nash investor conference
BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ca...
October 17, 2023, 8:01 am
Is spdr s&p biotech etf (xbi) a strong etf right now?
The SPDR S&P biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund t...
October 17, 2023, 7:31 am
Poolbeg pharma up 8% on deal with nasdaq biotech
Shares in Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) rose 8% in early trading after the company announced a partnership with an unnamed Nasdaq-listed ...
October 17, 2023, 4:03 am
Poolbeg pharma inks collaboration agreement with nasdaq biotech
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said it has inked an agreement with an unnamed Nasdaq-listed biopharmaceutical entity aimed at developing ...
October 17, 2023, 2:57 am
Sava stock continues to plunge on misconduct allegations
Big problems appear to be getting worse for Cassava Sciences (NASDAQ: SAVA ). The clinical-stage biotech ...
October 16, 2023, 5:26 pm
Moderna shares slump amid concerns about covid-19 vaccine demand
Moderna (MRNA) was the worst-performing stock in the S&P 500 on Monday as shares lost over 6% after the biotec...
October 16, 2023, 4:55 pm
: aldeyra therapeutics stock plunges on heavy volume after fda finds ‘substantive’ issues with nda for dry-eye disease treatment
Shares of Aldeyra Therapeutics Inc. ALDX plummeted 61.9% toward a 3 1/2-year low in very active morning trading Monday, enough to pace the Nasdaq’s ...
October 16, 2023, 3:50 pm
Prothena shares buoyed by sale rumors
Shares of Prothena Corporation (NASDAQ:PRTA) added almost 25% on rumours the biotechnology firm is exploring a sale ahead of the release of key data f...
October 16, 2023, 12:09 pm
Will diagnostic unit weakness mar danaher's (dhr) q3 earnings?
Danaher's (DHR) Q3 results are likely to be hurt by weakness in the Biotechnology and Diagnostics segments due to a decrease in the sale of COVID-rela...
October 16, 2023, 12:02 pm
Prothena prepares for potential sale - bloomberg news
biotech firm Prothena Corp is preparing for a potential sale, Bloomberg News reported on Monday, citing...
October 16, 2023, 11:57 am
Aldeyra therapeutics stock plunges on heavy volume after fda finds ‘substantive' issues with nda for dry-eye disease treatment
Shares of Aldeyra Therapeutics Inc. ALDX, -66.43% plummeted 61.9% toward a 3 1/2-year low in very active morning trading Monday, enough to pace the Na...
October 16, 2023, 11:50 am
: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is...
October 16, 2023, 11:11 am
Lyra therapeutics announces appointment of ronan o’brien as chief legal officer
WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotec...
October 16, 2023, 11:00 am
Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc
Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC CAMBRIDG...
October 16, 2023, 11:00 am
Is novavax stock a buy now?
Novavax's coronavirus vaccine is one of the few currently authorized in the U.S. However, the company's competition is fierce in a market whose size i...
October 16, 2023, 6:34 am